口内炎治療薬市場：薬剤クラス別、製剤別、エンドユーザー別-2025-2030年の世界予測

口内炎治療薬市場は、2023年に12億3,000万米ドルと評価され、2024年には13億米ドルに達すると予測され、CAGR 5.26％で成長し、2030年には17億7,000万米ドルに達すると予測されています。

口内炎治療薬市場には、口腔内に発生する痛みを伴うただれである口内炎（アフタ性潰瘍）の症状を緩和し、治癒を促進することを目的とした製品や治療法が含まれます。これらの治療の必要性は、ストレス、栄養不足、特定の健康状態などの原因により人口のかなりの部分が罹患する口内炎の流行から生じています。口内炎治療の用途には、市販のジェル、クリーム、洗浄剤、処方薬などがあり、即時の緩和と治癒の促進を目標としています。最終用途分野には、病院、歯科医院、在宅ケアの現場が含まれ、専門的な歯科治療からセルフケアソリューションまで幅広い消費者層を反映しています。市場を牽引する主な成長要因としては、口腔の健康に対する意識の高まり、医薬品製剤の進歩、即時緩和ソリューションに対する需要の高まりなどが挙げられます。オーガニック製品に対する消費者の嗜好の高まりを反映し、天然素材やハーブをベースとした治療法の開発に新たなビジネスチャンスが眠っています。さらに、都市化の進展とライフスタイルの変化が予防医療への注目を促し、予防医療ソリューションを革新する機会を企業に与えています。しかし、市場の成長には、製品の有効性に対する懸念、潜在的な副作用、新興市場における価格圧力といった要因が立ちはだかる。さらに、発展途上地域における認知度の低さも制約要因となっています。薬物徐放のためのナノテクノロジー応用や、標的治療のためのバイオテクノロジーの利用には革新が見られます。予測モデリングと個別化治療計画のための研究における人工知能のより大きな統合は、ビジネス成長のフロンティアを示しています。副作用の最小化とドラッグデリバリーの有効性の最大化に焦点を当てた調査は、治療成績の改善につながります。市場競争は、既存製薬企業や新規参入企業がバイオフレンドリーでコスト効率の高いソリューションを模索する中で続いており、市場でのプレゼンスを維持し、新たな機会を活用するためには、戦略的提携と継続的イノベーションが重要であることが強調されています。

市場力学：急速に進化する口内炎治療薬市場の主要市場インサイトを公開

口内炎治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界人口の口内炎有病率の高さ
  • 口内炎治療用の市販製品の入手可能性
  • 患者中心の口腔潰瘍治療計画の重視の高まり
• 市場抑制要因
  • 口内炎に対する既存の治療法の有効性が限定的であること
• 市場機会
  • より効果的な新しい口内炎治療のイントロダクション
  • ヘルスケア支出の増加と口腔衛生への注目の高まり
• 市場の課題
  • 口内炎に伴う特定の副作用

ポーターの5つの力：口内炎治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：口内炎治療薬市場における外部からの影響の把握

外部マクロ環境要因は、口内炎治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析口内炎治療薬市場における競合情勢の把握

口内炎治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス口内炎治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、口内炎治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨口内炎治療薬市場における成功への道筋を描く

口内炎治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界の人口における口内炎の有病率の高さ
    • 口内炎治療のための市販薬の入手可能性
    • 患者中心のケアの重要性が増す口内炎治療計画
  • 抑制要因
    • 口内炎に対する既存の治療法の有効性は限られている
  • 機会
    • より効果的な新しい口内炎治療法のイントロダクション
    • ヘルスケア費の増加と口腔衛生への関心の高まり
  • 課題
    • 口内炎に関連する特定の副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 口内炎治療薬市場薬剤クラス別

• 鎮痛剤
• 抗ヒスタミン薬
• 抗菌性
• コルチコステロイド

第7章 口内炎治療薬市場処方別

• ジェルと軟膏
• マウスウォッシュ
• スプレー

第8章 口内炎治療薬市場：エンドユーザー別

• 歯科医院
• 病院

第9章 南北アメリカの口内炎治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の口内炎治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの口内炎治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Apotex Inc.
• Blairex Laboratories Inc
• Blistex Inc.
• Bristol-Myers Squibb Company
• Church & Dwight, Inc.
• Colgate-Palmolive Company
• Dr. Reddy's Laboratories Ltd
• EPIEN Medical Inc.
• GlaxoSmithKline PLC
• Guilin Sanjin Pharmaceutical Co Ltd
• ICPA Health Products Ltd.
• Intas Pharmaceuticals Ltd.
• LloydsPharmacy Limited
• Meta Tubex Private Limited
• Patterson Dental Supply, Inc.
• Pfizer Inc.
• Prince Care Pharma Private Limited
• Raptakos Brett & Company Limited
• Reckitt Benckiser Group PLC
• Sinclair Pharma Ltd.
• STADA Arzneimittel AG
• Sun Pharmaceutical Industries Ltd
• Sunstar Suisse S.A
• Taro Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. MOUTH ULCERS TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. MOUTH ULCERS TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. MOUTH ULCERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. MOUTH ULCERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MOUTH ULCERS TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MOUTH ULCERS TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANTIHISTAMINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY MOUTHWASH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 30. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 47. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 50. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 102. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 114. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 117. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. MOUTH ULCERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. MOUTH ULCERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Mouth Ulcers Treatment Market was valued at USD 1.23 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 5.26%, to USD 1.77 billion by 2030.

The scope of the mouth ulcers treatment market encompasses the products and therapies aimed at alleviating the symptoms and promoting healing of mouth ulcers, or aphthous ulcers, which are painful sores that occur in the oral cavity. The necessity for these treatments arises from the prevalence of mouth ulcers, which affect a significant portion of the population due to causes like stress, nutritional deficiencies, and certain health conditions. Applications of mouth ulcer treatments include over-the-counter gels, creams, rinses, and prescribed medications, targeting immediate relief and accelerated healing. End-use segments involve hospitals, dental clinics, and home care settings, reflecting a broad consumer base from professional dental care to self-care solutions. Key growth factors driving the market include increasing awareness about oral health, advancements in pharmaceutical formulations, and the rising demand for quick-relief solutions. Emerging opportunities lie in the development of natural or herbal-based treatments, reflecting growing consumer preference for organic products. Furthermore, increasing urbanization and lifestyle changes are encouraging preventive care focus, presenting opportunities for companies to innovate preventive care solutions. However, market growth is challenged by factors like product efficacy concerns, potential side effects, and pricing pressures in emerging markets. Additionally, the lack of awareness in developing regions acts as a constraint. Innovations are seen in nanotechnology applications for sustained drug release and the use of biotechnology for targeted therapies. Greater integration of artificial intelligence in research for predictive modeling and personalized treatment plans represents a frontier for business growth. Research focused on minimizing side-effects and maximizing drug delivery efficacy is poised to improve treatment outcomes. The market remains competitive with established pharmaceutical companies and new entrants exploring bio-friendly and cost-effective solutions, emphasizing the importance of strategic alliances and continuous innovation to maintain market presence and leverage new opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mouth Ulcers Treatment Market

The Mouth Ulcers Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High prevalence of mouth ulcers among global population
  • Availability of over-the-counter products for mouth ulcer treatment
  • Growing emphasis on patient-centric care mouth ulcer treatment plans
• Market Restraints
  • Limited efficacy of existing treatments for mouth ulcers
• Market Opportunities
  • Introduction of new and more effective mouth ulcer treatments
  • Rising healthcare expenditure and increased focus on oral health
• Market Challenges
  • Certain side effects associated with mouth ulcers

Porter's Five Forces: A Strategic Tool for Navigating the Mouth Ulcers Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mouth Ulcers Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mouth Ulcers Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mouth Ulcers Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mouth Ulcers Treatment Market

A detailed market share analysis in the Mouth Ulcers Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mouth Ulcers Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mouth Ulcers Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mouth Ulcers Treatment Market

A strategic analysis of the Mouth Ulcers Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mouth Ulcers Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Apotex Inc., Blairex Laboratories Inc, Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight, Inc., Colgate- Palmolive Company, Dr. Reddy's Laboratories Ltd, EPIEN Medical Inc., GlaxoSmithKline PLC, Guilin Sanjin Pharmaceutical Co Ltd, ICPA Health Products Ltd., Intas Pharmaceuticals Ltd., LloydsPharmacy Limited, Meta Tubex Private Limited, Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, Raptakos Brett & Company Limited, Reckitt Benckiser Group PLC, Sinclair Pharma Ltd., STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd, Sunstar Suisse S.A, and Taro Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Mouth Ulcers Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Class, market is studied across Analgesics, Antihistamine, Antimicrobial, and Corticosteroids.
• Based on Formulation, market is studied across Gels & Ointments, Mouthwash, and Sprays.
• Based on End-User, market is studied across Dental Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of mouth ulcers among global population
    • 5.1.1.2. Availability of over-the-counter products for mouth ulcer treatment
    • 5.1.1.3. Growing emphasis on patient-centric care mouth ulcer treatment plans
  • 5.1.2. Restraints
    • 5.1.2.1. Limited efficacy of existing treatments for mouth ulcers
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of new and more effective mouth ulcer treatments
    • 5.1.3.2. Rising healthcare expenditure and increased focus on oral health
  • 5.1.4. Challenges
    • 5.1.4.1. Certain side effects associated with mouth ulcers
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Mouth Ulcers Treatment Market, by Drug Class

• 6.1. Introduction
• 6.2. Analgesics
• 6.3. Antihistamine
• 6.4. Antimicrobial
• 6.5. Corticosteroids

7. Mouth Ulcers Treatment Market, by Formulation

• 7.1. Introduction
• 7.2. Gels & Ointments
• 7.3. Mouthwash
• 7.4. Sprays

8. Mouth Ulcers Treatment Market, by End-User

• 8.1. Introduction
• 8.2. Dental Clinics
• 8.3. Hospitals

9. Americas Mouth Ulcers Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Mouth Ulcers Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Mouth Ulcers Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Apotex Inc.
• 3. Blairex Laboratories Inc
• 4. Blistex Inc.
• 5. Bristol-Myers Squibb Company
• 6. Church & Dwight, Inc.
• 7. Colgate- Palmolive Company
• 8. Dr. Reddy's Laboratories Ltd
• 9. EPIEN Medical Inc.
• 10. GlaxoSmithKline PLC
• 11. Guilin Sanjin Pharmaceutical Co Ltd
• 12. ICPA Health Products Ltd.
• 13. Intas Pharmaceuticals Ltd.
• 14. LloydsPharmacy Limited
• 15. Meta Tubex Private Limited
• 16. Patterson Dental Supply, Inc.
• 17. Pfizer Inc.
• 18. Prince Care Pharma Private Limited
• 19. Raptakos Brett & Company Limited
• 20. Reckitt Benckiser Group PLC
• 21. Sinclair Pharma Ltd.
• 22. STADA Arzneimittel AG
• 23. Sun Pharmaceutical Industries Ltd
• 24. Sunstar Suisse S.A
• 25. Taro Pharmaceutical Industries Ltd.